logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Triptorelin CAS 57773-63-4 API Active Pharmaceutical Ingredient

Triptorelin CAS 57773-63-4 API Active Pharmaceutical Ingredient

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 57773-63-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,Western Union,T/T,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:

Triptorelin CAS 57773-63-4

,

CAS 57773-63-4

CAS NO::
57773-63-4
Appearance::
Powder
Molecular Formula::
C64H82N18O13
Molecular Weight::
1311.45000
EINECS NO::
637-328-4
MDL NO::
MFCD00167541
CAS NO::
57773-63-4
Appearance::
Powder
Molecular Formula::
C64H82N18O13
Molecular Weight::
1311.45000
EINECS NO::
637-328-4
MDL NO::
MFCD00167541
Triptorelin CAS 57773-63-4 API Active Pharmaceutical Ingredient

Product Description:

Product Name: Triptorelin CAS NO: 57773-63-4


Synonyms:

PGLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2;

PYROGLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY NH2;

TRIPTORELIN AMIDE;


Chemical & Physical Properties:

Appearance: Powder

Assay :≥99.00%

Density: 1.52 g/cm3

Storage Condition: -20℃


Safety Information:

Safety Statements: S53-22-36/37/39-45

WGK Germany: 3

Risk Statement: R60

Hazard Code: T


Triptorelin, a decapeptide (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2), is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, e-strogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. It is also used as therapy in cases of gender dysphoria. Triptorelin is marketed under the brand names Decapeptyl (Ipsen) and Diphereline and Gonapeptyl (Ferring Pharmaceuticals). In the United States, it is sold by Watson Pharmaceuticals as Trelstar. In Iran Triptorelin is marketed under the brand name Variopeptyl (Varian Darou Pajooh).

During the treatment of prostate cancer it does cause a surge of t-estosterone (an initial uplevel of t-estosterone levels), known as a flare effect. In men a reduction of serum t-estosterone levels into the range normally seen after surgical castration occurs approximately two to four weeks after initiation of therapy. In contrast, gonadotropin-releasing hormone antagonists do not cause a surge, but a sudden reduction of t-estosterone levels. Systematic IUPAC Name: [d-Trp6]GnRH.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.